Biopharmaceutical Scientist vs Molecular Biologist: which career is safer from AI?
Biopharmaceutical Scientist is the safer bet: future safety 75/100 against 65/100 for Molecular Biologist.
| Biopharmaceutical Scientist | Molecular Biologist | |
|---|---|---|
| AI risk by 2035 | 30/100 | 35/100 |
| Future safety | 75/100 | 65/100 |
| Jobs in India | Demand growing | Demand steady |
| Starting salary | ₹4 - ₹6 Lakh/annum | — |
| First to go to AI | Documenting experiments and results to GMP and regulatory standards | Recording lab data and analysing results with statistical and bioinformatics tools |
| Verdict | Safe if you go past routine QC: AI is taking the paperwork and data crunching, not the bench and the batch. | Safe if you combine wet-lab skills with bioinformatics: AI speeds up the data, not the bench work. |
| Salary in 2035 | ₹00 - ₹00 Lakh | ₹00 - ₹00 Lakh |
Unlock both full reports free
Free, takes 30 seconds. Already have an account? Log in
Will AI replace Biopharmaceutical Scientist? Full outlook →Will AI replace Molecular Biologist? Full outlook →
Still stuck between Biopharmaceutical Scientist and Molecular Biologist?
Two good careers can be a bad fit for the same person. The career test compares both against your interests, aptitude and personality, and a counsellor helps you decide.